COVID Didn’t Seem to Slow Down FDA Drug Approvals
While COVID-19 has impacted almost every facet of our lives over the last few years, one area that it didn’t seem to have a huge impact on is drug approvals by the United States Food and Drug Administration (FDA). Average review time in the United States did not decrease either during the pandemic nor in the early months following the re-opening of…
Read More...